BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14668795)

  • 1. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
    Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
    Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
    Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
    Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
    Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.
    Pendino F; Hillion J; Dudognon C; Delaunay J; Mourah S; Podgorniak MP; Lafon I; Chomienne C; Lanotte M; Dombret H; Rousselot P; Ségal-Bendirdjian E
    Leukemia; 2006 Apr; 20(4):599-603. PubMed ID: 16482212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E; Lillehaug JR; Gaub MP; Lanotte M
    Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
    Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E
    Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells.
    Idres N; Marill J; Chabot GG
    Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
    Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E
    Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.
    Chattopadhyay N; Butters RR; Brown EM
    Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
    Makishima M; Shudo K; Honma Y
    Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
    Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
    Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation.
    Benoit G; Altucci L; Flexor M; Ruchaud S; Lillehaug J; Raffelsberger W; Gronemeyer H; Lanotte M
    EMBO J; 1999 Dec; 18(24):7011-8. PubMed ID: 10601023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct actions of retinoid-receptor ligands.
    Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
    Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.